Back
ACADIA Pharmaceuticals Quote, Financials, Valuation and Earnings
$50 trade to make today with huge potential!
Click here to access my #1 options strategy for overnight wins starting with $50!
Sell
39
ACAD
ACADIA Pharmaceuticals
Last Price:
16.33
Seasonality Move:
5.15%
7 Day Trial
ALL ACCESS PASS
$
7
I love this overnight trade happening Thursday
Access my free presentation on these overnight trades right hereACADIA Pharmaceuticals Price Quote
$16.33
-0.26 (-1.57%)
(Updated: April 25, 2024 at 4:20 PM ET)
ACADIA Pharmaceuticals Key Stats
Sell
39
ACADIA Pharmaceuticals (ACAD)
is a Sell
Day range:
$16.55 - $16.86
52-week range:
$16.55 - $33.99
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
3.75
P/B ratio:
6.33%
Volume:
1.2M
Avg. volume:
1.7M
1-year change:
-17.63%
Market cap:
$2.7B
Revenue:
$726.4M
EPS:
$-0.38
How Much Does ACADIA Pharmaceuticals Make?
-
How Much Are ACADIA Pharmaceuticals's Sales Annually?
ACAD Revenues are $726.4M -
How Much Profit Does ACADIA Pharmaceuticals's Make A Year?
ACAD net income is -$61.3M
Is ACADIA Pharmaceuticals Growing As A Company?
-
What Is ACADIA Pharmaceuticals's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.69% -
What Is ACADIA Pharmaceuticals's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
ACADIA Pharmaceuticals Stock Price Performance
-
Did ACADIA Pharmaceuticals Stock Go Up Last Month?
ACADIA Pharmaceuticals share price went down by -7.58% last month -
Did ACAD's Share Price Rise Over The Last Year?
ACAD share price fell by -17.63% over the past 1 year
What Is ACADIA Pharmaceuticals 52-Week High & Low?
-
What Is ACADIA Pharmaceuticals’s 52-Week High Share Price?
ACADIA Pharmaceuticals has traded as high as $33.99 over the past 52 weeks -
What Is ACADIA Pharmaceuticals’s 52-Week Low Share Price?
ACADIA Pharmaceuticals has traded as low as $16.55 over the past 52 weeks
ACADIA Pharmaceuticals Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy ACADIA Pharmaceuticals?
-
How Much Debt Does ACADIA Pharmaceuticals Have?
Total long term debt quarterly is $0 -
How Much Cash Does ACADIA Pharmaceuticals Have?
Cash and short term investments quarterly total is $438.9M -
What Is ACADIA Pharmaceuticals’s Book Value Per Share?
Book value per share is 2.62
Is ACADIA Pharmaceuticals Cash Flow Positive?
-
What Is ACAD Cash Flow From Operations?
Cash flow from operations (TTM) is $16.7M -
What Is ACADIA Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is $25.1M -
What Is ACADIA Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is $32M
ACADIA Pharmaceuticals Return On Invested Capital
-
Is Management Doing A Good Job?
ACAD return on invested capital is -15.6% -
What Is ACADIA Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is -9.38% -
What Is ACAD Return On Equity?
ROE is a measure of profitability and is -15.6%
ACADIA Pharmaceuticals Earnings Date & Stock Price
-
What Is ACADIA Pharmaceuticals's Stock Price Today?
A single share of ACAD can be purchased today for 16.59 -
What Is ACADIA Pharmaceuticals’s Stock Symbol?
ACADIA Pharmaceuticals trades on the nasdaq under the ticker symbol: ACAD -
When Is ACADIA Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for ACADIA Pharmaceuticals is scheduled on May 8, 2024 -
When Is ACAD's next ex-dividend date?
ACADIA Pharmaceuticals's next ex-dividend date is May 26, 2020 -
How To Buy ACADIA Pharmaceuticals Stock?
You can buy ACADIA Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
ACADIA Pharmaceuticals Competitors
-
Who Are ACADIA Pharmaceuticals's Competitors?
Below is a list of companies who compete with ACADIA Pharmaceuticals or are related in some way:
ACADIA Pharmaceuticals Dividend Yield
Data Unavailable
ACADIA Pharmaceuticals Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | -9.51% |
| Revenue: | 69.27% | 3.24% |
Analyst Recommendations
| Buy Recommendations: | 9 |
|---|---|
| Hold Recommendations: | 5 |
| Sell Recommendations: | 0 |
| Price Target: | 29.09 |
| Upside from Last Price: | 75.37% |